PDR001 Plus LAG525 for Patients With Advanced Solid and Hematologic Malignancies

Clinical trial NCT03365791 · COMPLETED

Trial details

NCT number: NCT03365791
Sponsor: Novartis Pharmaceuticals
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Small Cell Lung Cancer Gastric Adenocarcinoma Esophageal Adenocarcinoma Castration Resistant Prostate Adenocarcinoma Soft Tissue Sarcoma Ovarian Adenocarcinoma Advanced Well-differentiated Neuroendocrine Tumors Diffuse Large B Cell Lymphoma

Start date: 2018-01-24
Primary completion: 2019-02-21
Enrollment: 76

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.